Annual EBITDA
Summary
- Current Value
- As of today, ABUS annual EBITDA is -$68.59M, up +10.49% on
- Historical Performance
- ABUS annual EBITDA is up +1.86% over the past 3 years, and up +1.04% over the past 5 years
- All-Time High Comparison
- ABUS annual EBITDA is currently -1384.27% below its historical high of $5.34M set on
- 3-Year Low Comparison
- ABUS annual EBITDA is +10.49% above its 3-year low of -$76.63M reached on
- Sector Comparison
- ABUS annual EBITDA is higher than 23.01% of companies in Healthcare sector
EBITDA Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$68.59M | +10.5% | +1.9% | +1.0% | -944.7% | |
| Quarterly EBITDA | -$8.28M | +51.7% | +52.0% | +43.3% | -334.2% | |
| TTM EBITDA | -$30.67M | +60.2% | +50.0% | +41.3% | -442.3% | |
| Price | $4.50 | +34.3% | +57.9% | +11.4% | -24.0% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $6.17M | -66.0% | -43.8% | +2.7% | -51.2% | |
| Annual EPS | -$0.38 | +14.2% | +54.7% | +87.0% | -126.1% | |
| -$69.97M | +10.3% | +2.3% | +1.9% | -740.7% | ||
| Annual Net Income | -$69.92M | +4.0% | +8.3% | +54.5% | -716.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$61.80M | N/A | -11.0% |
| 5Y | -$55.29M | N/A | -24.1% |
| All | $5.34M | -1384.3% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$76.63M | +10.5% | |
| 5Y | -$76.63M | +10.5% | |
| All | -$76.63M | +10.5% |
EBITDA History
FAQ
What is the current annual EBITDA of ABUS?
As of today, ABUS annual EBITDA is -$68.59M
What is 1-year change in ABUS annual EBITDA?
ABUS annual EBITDA is up +10.49% year-over-year
What is 3-year change in ABUS annual EBITDA?
ABUS annual EBITDA is up +1.86% over the past 3 years
How far is ABUS annual EBITDA from its all-time high?
ABUS annual EBITDA is currently -1384.27% below its historical high of $5.34M set on December 31, 2006
How does ABUS annual EBITDA rank versus sector peers?
ABUS annual EBITDA is higher than 23.01% of companies in Healthcare sector
When is ABUS next annual earnings release?
The next annual earnings release for ABUS is on
Quarterly EBITDA
Summary
- Current Value
- As of today, ABUS quarterly EBITDA is -$8.28M, down -530.46% on
- Historical Performance
- ABUS quarterly EBITDA is up +51.67% year-over-year, and up +52.00% over the past 3 years
- All-Time High Comparison
- ABUS quarterly EBITDA is currently -200.64% below its historical high of $8.23M set on
- 3-Year Low Comparison
- ABUS quarterly EBITDA is +60.59% above its 3-year low of -$21.02M reached on
- Sector Comparison
- ABUS quarterly EBITDA is higher than 35.08% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$8.28M | -530.5% | +51.7% | +52.0% | +43.3% | |
| Annual EBITDA | -$68.59M | – | +10.5% | +1.9% | +1.0% | |
| TTM EBITDA | -$30.67M | +22.4% | +60.2% | +50.0% | +41.3% | |
| Price | $4.50 | +5.1% | +34.3% | +57.9% | +11.4% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $529.00K | -95.1% | -60.5% | -91.1% | -65.3% | |
| Quarterly EPS | -$0.04 | -408.4% | +61.3% | +65.3% | +85.3% | |
| -$8.29M | -533.5% | +52.5% | +52.9% | +45.1% | ||
| Quarterly Net Income | -$7.74M | -406.9% | +60.7% | +55.9% | +58.7% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.92M | -530.5% | |
| 3Y | $1.92M | -530.5% | |
| 5Y | $1.92M | -530.5% | |
| All | $8.23M | -200.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$12.70M | +34.8% | |
| 3Y | -$21.02M | +60.6% | |
| 5Y | -$21.02M | +60.6% | |
| All | -$22.77M | +63.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ABUS?
As of today, ABUS quarterly EBITDA is -$8.28M
What is ABUS quarterly EBITDA most recent change?
ABUS quarterly EBITDA was down -530.46% on September 30, 2025
What is 1-year change in ABUS quarterly EBITDA?
ABUS quarterly EBITDA is up +51.67% year-over-year
How far is ABUS quarterly EBITDA from its all-time high?
ABUS quarterly EBITDA is currently -200.64% below its historical high of $8.23M set on March 1, 2005
How does ABUS quarterly EBITDA rank versus sector peers?
ABUS quarterly EBITDA is higher than 35.08% of companies in Healthcare sector
When is ABUS next earnings release?
The next earnings release for ABUS is on
TTM EBITDA
Summary
- Current Value
- As of today, ABUS TTM EBITDA is -$30.67M, up +22.40% on
- Historical Performance
- ABUS TTM EBITDA is up +60.24% year-over-year, and up +49.99% over the past 3 years
- All-Time High Comparison
- ABUS TTM EBITDA is currently -472.31% below its historical high of $8.24M set on
- 3-Year Low Comparison
- ABUS TTM EBITDA is +62.13% above its 3-year low of -$80.99M reached on
- Sector Comparison
- ABUS TTM EBITDA is higher than 38.34% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$30.67M | +22.4% | +60.2% | +50.0% | +41.3% | |
| Annual EBITDA | -$68.59M | – | +10.5% | +1.9% | +1.0% | |
| Quarterly EBITDA | -$8.28M | -530.5% | +51.7% | +52.0% | +43.3% | |
| Price | $4.50 | +5.1% | +34.3% | +57.9% | +11.4% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $14.61M | -5.3% | +116.6% | -59.4% | +137.7% | |
| TTM EPS | -$0.22 | +22.4% | +47.9% | +52.7% | +81.9% | |
| -$31.36M | +22.6% | +60.1% | +50.1% | +42.2% | ||
| TTM Net Income | -$42.28M | +22.1% | +44.9% | +38.6% | +40.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$30.67M | at high | |
| 3Y | -$30.67M | at high | |
| 5Y | -$30.67M | at high | |
| All | $8.24M | -472.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$68.59M | N/A | +55.3% |
| 3Y | -$80.99M | +62.1% | |
| 5Y | -$80.99M | +62.1% | |
| All | -$80.99M | +62.1% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ABUS?
As of today, ABUS TTM EBITDA is -$30.67M
What is ABUS TTM EBITDA most recent change?
ABUS TTM EBITDA was up +22.40% on September 30, 2025
What is 1-year change in ABUS TTM EBITDA?
ABUS TTM EBITDA is up +60.24% year-over-year
How far is ABUS TTM EBITDA from its all-time high?
ABUS TTM EBITDA is currently -472.31% below its historical high of $8.24M set on March 1, 2007
How does ABUS TTM EBITDA rank versus sector peers?
ABUS TTM EBITDA is higher than 38.34% of companies in Healthcare sector
When is ABUS next earnings release?
The next earnings release for ABUS is on
EBITDA Formula
Data Sources & References
- ABUS Official Website www.arbutusbio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1447028/000144702825000126/0001447028-25-000126-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1447028/000144702825000083/0001447028-25-000083-index.htm
- ABUS Profile on Yahoo Finance finance.yahoo.com/quote/ABUS
- ABUS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abus
